System for performing remote ischemic conditioning

- CellAegis Devices Inc.

A system for performing remote ischemic conditioning includes an inflatable cuff configured to encircle a limb of a subject and a controller removably attached to the cuff. The controller includes a pump; a manifold in fluid communication with the pump; a connector in fluid communication with the manifold and in removable fluid communication with the inflatable cuff; a pressure sensor; and a control circuit configured to implement a remote ischemic conditioning treatment protocol.

Skip to: Description  ·  Claims  ·  References Cited  · Patent History  ·  Patent History
Description
RELATED APPLICATIONS

This application is a continuation of and claims priority to U.S. patent application Ser. No. 13/088,243, entitled “System For Performing Remote Ischemic Conditioning,” filed Apr. 15, 2011, the entire disclosure of which is incorporated herein by reference.

FIELD

This invention relates generally to systems for performing remote ischemic conditioning, and more particularly, to systems for performing remote ischemic conditioning incorporating a removable controller.

BACKGROUND

Ischemic diseases are significant causes of mortality in industrialized nations. It is well established that tissue damage results from ischemia (insufficient blood flow to a tissue) followed by reperfusion (reflow of blood to the tissue). Ischemia and reperfusion cause disturbance of microcirculation with ensuing tissue damage and organ dysfunction. Organs such as the kidney, heart, liver, pancreas, lung, brain and intestine are known to sustain damage following ischemia and reperfusion.

In ischemic conditioning (IC), a tissue or organ or region of a subject's body is deliberately subjected to brief ischemic episodes, followed by brief reperfusion episodes. IC has been found to render the tissue, organ or region resistant to injury during subsequent ischemic episodes. The phenomenon of ischemic conditioning has been demonstrated in most mammalian tissues. IC is now recognized as one of the most potent innate protective mechanisms against ischemia-reperfusion (I-R) injury.

Remote ischemic conditioning (RIC) refers to the deliberate induction of transient ischemia in a subject at a region remote from at least some of the tissue to be protected. Often, RIC includes inducing transient ischemia in a subject's limb to protect organs remote from the limb, such as the myocardium. Myocardial protection has been demonstrated by a variety of remote stimuli, including renal ischemia, liver ischemia, mesenteric artery ischemia, and skeletal muscle hind limb ischemia.

RIC, in the broadest sense, involves deliberate induction of an ischemic period followed by a reperfusion period. The ischemic period may involve complete cessation of blood flow (blood flow occlusion). Such ischemic periods may be induced by applying super-systolic pressures on a region of the body, such as for example a limb. Alternatively, ischemic periods may also be induced by applying a less than systolic pressure.

RIC may be performed prior to (pre-), during (per-) and/or following (post-) an ischemic injury or other injury which benefits from RIC. RIC has shown benefit in reducing or preventing damage resulting from, myocardial infarction and trauma, inter alia.

SUMMARY

In one aspect, a device for performing RIC includes an inflatable cuff configured to encircle a limb of a subject and a controller removably attached to the cuff. The controller includes a pump; a manifold in fluid communication with the pump; an outlet in fluid communication with the manifold and in removable fluid communication with the inflatable cuff; a pressure sensor; and a control circuit configured to implement a RIC treatment protocol.

In another aspect, a cuff assembly may be adapted to encircle a limb of a subject. The cuff assembly includes an inner layer, an outer layer, and a bladder disposed between the inner layer and the outer layer. The outer layer includes two flexible foam sections spaced apart in a longitudinal direction of the cuff assembly. The outer layer also includes an intermediate section disposed between the two flexible foam sections. The intermediate section may have a greater rigidity than the two flexible foam sections.

In a further aspect, a device includes an inflatable cuff and a controller attachment section. The inflatable cuff may be configured to encircle a limb of a subject. The cuff has an axial direction substantially parallel to an axis of the limb when the cuff is in the fitted state. The controller attachment section may be operatively attached to the cuff by at least one attachment joint oriented substantially parallel to the axial direction of the cuff. The controller attachment section may include a connector adapted for removable attachment of a controller. The controller attachment section may provide fluid communication between the controller and cuff in a location removed from the connector when the controller is in an attached state.

It should be appreciated that all combinations of the foregoing aspects and additional concepts discussed in greater detail below (provided such concepts are not mutually inconsistent) are contemplated as being part of the inventive subject matter disclosed herein.

The foregoing and other aspects, embodiments, and features of the present teachings can be more fully understood from the following description in conjunction with the accompanying drawings.

BRIEF DESCRIPTION OF THE DRAWINGS

The accompanying drawings are not intended to be drawn to scale. In the drawings, each identical or nearly identical component that is illustrated in various figures is represented by a like numeral. For purposes of clarity, not every component may be labeled in every drawing. Various embodiments of the invention will now be described, by way of example, with reference to the accompanying drawings, in which:

FIG. 1 is a schematic perspective view of an assembled system for remote ischemic conditioning with a removable controller;

FIG. 2 is a schematic perspective view of the system for remote ischemic conditioning depicted in FIG. 1 with the controller removed;

FIG. 3 is a cross sectional view of the system for remote ischemic conditioning depicted in FIG. 1 taken along the line 3-3 in FIG. 1;

FIG. 4 is an exploded schematic perspective view of the cuff of the system depicted in FIG. 1;

FIG. 5 is a schematic top perspective view of the controller attachment section of the system depicted in FIG. 1;

FIG. 6 is a schematic bottom perspective view of the controller attachment section of the system depicted in FIG. 1;

FIG. 7 is a schematic bottom perspective view of the controller of the system depicted in FIG. 1;

FIG. 8 is a schematic top perspective view of the controller of the system depicted in FIG. 1;

FIG. 9 is a cross sectional view of the controller and controller attachment section while coupled to the system depicted in FIG. 1;

FIG. 9A is a detailed view of FIG. 9 corresponding to box A of FIG. 9;

FIG. 10 is a schematic perspective view of the controller of the system depicted in FIG. 1 with the cover removed;

FIG. 11 is a schematic perspective view of the controller of the system depicted in FIG. 1 with the cover and PCB removed;

FIG. 12. is a schematic perspective view of a charging cradle to be used with the controller; and

FIG. 13 is a schematic perspective view of the charging cradle of FIG. 12 with an optional wall mount.

 DETAILED DESCRIPTION

The illustrative embodiments described herein are not necessarily intended to show all aspects of the invention. Aspects of the invention are not intended to be construed narrowly in view of the illustrative embodiments. It should be appreciated that the various concepts and embodiments introduced above and those discussed in greater detail below may be implemented in any of numerous ways, as the disclosed concepts and embodiments are not limited to any particular manner of implementation. In addition, it should be understood that aspects of the invention may be used alone or in any suitable combination with other aspects of the invention.

In one aspect, a system for performing RIC includes an inflatable cuff, a controller attachment section joined to the cuff, and a controller selectively removable from the controller attachment section. The controller may control the inflation and deflation of the inflatable cuff. Furthermore, the controller may include a control circuit programmed to implement an RIC protocol. In another aspect the cuff may be soft, rigid, and made from thermoformable materials.

Turning now to the figures, several possible embodiments are described in further detail.

FIGS. 1 and 2 illustrate one embodiment of a system 2 for RIC. System 2 may include an inflatable cuff 4, a controller attachment section 6, and a controller 8. In some embodiments, as depicted in FIG. 2, the controller 8 is selectively removable from system 2. The controller attachment section 6 may include an interlocking retaining tab 10 adapted to provide removable attachment of the controller. The controller attachment section may also include a conduit 12 that provides, sealed, fluid communication between the controller 8 and inflatable cuff 6.

In one aspect, cuff 4 is axially rigid while being soft or non-irritating to the skin. In one embodiment, cuff 4 may include an inner layer 16, a layer 18, and a selectively inflatable bladder 20 disposed between layers 16 and 18, as depicted in FIG. 4. Cuff 4 may be adapted to encircle a limb of an individual. Axis 15 represents the approximate center of a circular configuration formed when cuff 4 is wrapped about a patient's limb. An axial direction of cuff 4 corresponds to the approximate direction of axis 15. Cuff 4 has a longitudinal direction extending down the length of cuff 4 which is substantially perpendicular to the above defined axial direction. Cuff 4 may also be intended to be a disposable item for use with removable controller 8. Inner layer 16 typically is positioned adjacent to, and often in contact with, the skin of an individual wearing system 2. Since inner layer 16 may be in contact with skin, the inner layer may be made from a soft and/or non-irritating material. The inner layer 16 may be made from a knit, woven, or felted cloth. The cloth may include either natural or synthetic materials. Possible cloths include brushed polyester, brushed nylon, and/or other suitable materials as would be apparent to one of skill in the art. Alternatively, inner layer 16 may be made from a foam. In some embodiments, inner layer 16 may be further adapted to provide moisture absorption, wicking, and/or breathability to cuff 4.

In some embodiments, cuff 4 may include two sections 22 spaced apart in a longitudinal direction and an intermediate section 24 disposed between the sections 22. Intermediate section 24 may be constructed to have a greater rigidity than sections 22. The increased rigidity of the intermediate section 24 may be created either by an inherent material property difference, a difference in the physical construction (e.g. a thicker section and/or inclusion of reinforcing features), or both. In one embodiment, the intermediate section 24 may include a substantially flat outer surface 25 for attachment to the controller attachment section 6. Intermediate section 24 may also include an inner surface 26 which is curved in the longitudinal direction of the cuff 4. The curved inner surface 26 may be constructed so as to generally conform to the curvature of a limb. In some embodiments, the size and curvature of the cuff 4 may be suited for a variety of sizes and ages of patients ranging from neonates to obese adults. The cuff 4 may also be sized for either attachment to an arm or a leg. The intermediate section 24 may be constructed from thermosetting plastics, thermoforming plastics, and/or foamed materials. Sections 22 and the intermediate section 24 may be integrally formed with one another, or they may be formed separately and subsequently joined using any appropriate method including, but not limited to, a sewn seam, ultrasonic welds, adhesives, rivets, clamping structures, and/or mechanically interlocking features. Section 22 may be formed of a foam material or any other suitably flexible yet strong material.

In one embodiment, cuff 4 may also include a plurality of reinforcing structures 28 substantially aligned in the axial direction of the cuff assembly. Reinforcing structures 28 typically may be formed in outer layer 18 of sections 22. Reinforcing structures 28 provide axial rigidity to the cuff 4. The increased axial rigidity provided by reinforcing structures 28 helps to distribute the pressure applied by cuff 4 in the axial direction to provide a substantially uniform pressure across the axial width of the cuff 4. Reinforcing structures 28 may also help to prevent kinks in cuff 4 when it is placed around the arm or leg of an individual. Reinforcing structures 28 may be spaced apart in a longitudinal direction to permit the cuff 4 to easily bend around an encircled limb while still providing increased axial rigidity. Reinforcing structures 28 may be curved or straight in shape in the axial direction. In some embodiments, the reinforcing structures 28 may be integrally formed with the foam in sections 22 such as by the application of heat and/or pressure (e.g. thermoforming) to selectively melt and/or compress portions of the foam in sections 22. The uncompressed and/or unmelted portions of foam in sections 22 form the raised reinforcing structures 28. Alternatively, reinforcing structures 28 may be separately formed and subsequently joined to sections 22.

Layer 18 may also include a cloth layer 19 applied to an exterior surface. Cloth layer 19 may be formed of a low stretch or non-stretch cloth. The low stretch or non-stretch properties may be an inherent property of the cloth selected. Alternatively, cloth layer 19 may be a made from thermoformable materials and may be laminated to the exterior surface of layer 18. The lamination process may alter the thermoformable fabric to be a low stretch or non-stretch material. In one embodiment, the cloth may be applied to and laminated with layer 18 in a flat layout prior to forming reinforcing structures 28. Reinforcing structures 28 may subsequently be thermoformed to a final desired shape. The resulting sections 22 may be soft and have low stretch or non-stretch properties. Furthermore, sections 22 may be thermoformable enabling subsequent processing steps.

Selectively inflatable bladder 20 may be disposed between inner layer 16 and layer 18. Bladder 20 may have a valve 30 arranged and adapted to provide a fluid inlet to the interior of bladder 20. Valve 30 extends through a hole 32 in the intermediate section 24 of cuff 4. Valve 30 may be placed in sealed fluid communication with a corresponding structure 33 on controller attachment section 6 which may also be in sealed fluid communication with an outlet 48 of controller 8. When connected to outlet 48 of controller 8 through structure 33 of the controller attachment section 6, valve 30 may provide pressurized gas such as air to bladder 20. In some embodiments, bladder 20 may be a component separate from layers 16 and 18. Bladder 20 may be formed such as by bonding two separate sheets of thermoplastic polyurethane together. In other embodiments, bladder 20 may be formed from air impermeable layers incorporated into layers 16 and 18 of cuff 4. Layers of bladder 20 may be bonded together in an air tight manner using any number of methods including adhesives, ultrasonic welding, beads of material around the edges, and/or other appropriate methods as would be apparent to one of skill in the art. Bladder 20 may also be formed as a unitary structure without separate layers.

Layers 16, 18, 19, and bladder 20 of cuff 4 may be held together at their edges in any suitable fashion, such as by a binding material 36 wrapped around the edge of cuff 4 and sewn to cuff 4, as shown in FIG. 4. Alternatively, cuff 4 may be held together using adhesives, rivets, ultrasonic welds, or other appropriate methods as would be apparent to one of skill in the art.

In one aspect, it may be desirable to provide a non-slip interface to prevent cuff 4 from moving on the limb of a subject, since system 2 may be worn for protracted periods of time. To provide a non-slip interface, at least one non-slip structure 34 may be disposed on the face of inner layer 16. The non-slip structure 34 may be printed, glued, sewn, applied as a bead of material using a guided tool, or by hand. The non-slip structure 34 may include, but is not limited to, one or more strips of silicone.

The cuff 4 may also include fasteners to hold the cuff on a limb of a subject and to adjust the circumferential size of the cuff 4 when in the fitted state. Such fasteners include, but are not limited to, hook and loop fasteners, latches, ratchet mechanisms, clasps, snaps, buckles, and other appropriate structures as would be apparent to one of skill in the art. For example, the fastener may be a hook and loop fastener including a plurality of adjacent unconnected hook sections 38a disposed on layer 18 or 19 and loop sections 38b disposed on inner layer 16. Hook sections 38a may extend in the axial direction of the cuff 4. The width of each hook section 38a, with respect to the longitudinal direction of the cuff, may be selected to provide a flexible cuff able to wrap around different sized limbs.

The controller attachment section 6 of FIG. 1 is shown in more detail in FIGS. 3, 5 and 6. In one embodiment, controller attachment section 6 may include an upper surface 40 for supporting controller 8 in the attached state, a lower surface 44, and an upstanding wall 42 surrounding surface 40. A raised portion 43 of upstanding wall 42 may be located adjacent to and block a power inlet 52 of controller 8 in the attached state. By blocking access to power inlet 52 in the attached state, raised portion 43 may prevent use of the device while controller 8 is connected to an external power source. The controller attachment section 6 may also include a connector, such as retaining tab 10, arranged to provide removable attachment of controller 8. In one embodiment, tab 10 is mounted at one end to surface 40 and includes a projecting edge 41 spaced from surface 40 that faces outwardly towards wall 42. Bosses 45 are disposed on wall 42 on the opposite side of section 6 from tab 10. When controller 8 is attached to attachment section 6, the upper portion of tab 10 is pushed inwardly away from wall 42 so that it passes through slot 49 that is disposed between the body of controller 8 and an outer band 51, as shown in FIG. 7. At the same time, bosses 45 extend into recesses 53 of controller 8, as shown in FIG. 8. Tab 10 has sufficient resilience that when snapped into place, this resilience creates an outward bias on tab 10 that causes edge 41 to overlie the upper edge of band 51. To release controller 8, the upper portion of tab 10 is again pushed inwardly against its bias toward controller 8 until edge 41 overlies slot 49 and is clear of band 51 at which time controller 8 may be pulled out of attachment section 6 at the end closest to tab 10.

In one embodiment, lower surface 44 and/or bottom edge 46 of controller attachment section 6 may be disposed on and substantially conform to the shape of an outer surface of cuff 4. In some embodiments, bottom surface 44 and/or bottom edge 46 of the controller attachment section 6 may be disposed on and substantially conform to the shape of outer surface 25 of intermediate section 24 of cuff 4 shown in FIG. 4. As shown in FIG. 3, the controller attachment section 6 may be joined to outer surface 25 of intermediate section 24 of inflatable cuff 4 along lower surface 44 by at least one and typically two attachment joints 14. In one embodiment, the attachment joint(s) 14 may be oriented substantially parallel to axis 15 of the cuff. The attachment joint 14 may be formed using any appropriate method including, but not limited to, a sewn seam, an ultrasonic weld, an adhesive, and/or rivets. When two or more attachment joints 14 are included, the joints 14 may be spaced apart in the longitudinal direction to allow the cuff 4 to bend and conform to the shape of different sized limbs.

As shown in FIGS. 9 and 9A, controller attachment section 6 may provide fluid communication between the controller 8 and bladder 20 of cuff 4 via structure 33. Structure 33 may include a conduit 12 which is provided in a location spaced from retaining tab 10, when the controller 8 is in an attached state. Conduit 12 fluidly couples controller 8 to valve 30 of bladder 20. Conduit 12 may include a female section 12a that is constructed and arranged to mate with an outlet 48 of controller 8 and a male section 12b that is constructed and arranged to mate with valve 30 of bladder 20. Outlet 48 may include a fluid conduit 58. While a male and female connection have been described, the male and female portions could be reversed or even replaced with other comparable fluid connections, such as a tube or the like. A seal, such as O-ring 60, may be disposed on a shoulder 59 located in structure 33. The O-ring 60 may create a gland seal between female section 12a and outlet 48. Alternatively, a compression seal with O-ring 60 may be used. A retaining structure 61 may be included in structure 33 to retain O-ring 60. Retaining structure 61 may be joined to structure 33 using any appropriate method including, but not limited to, press fitting, ultrasonic welding, and/or adhesives.

As shown in FIG. 8, controller 8 has a front cover 50, which may include controls and displays, and a power inlet 52. Guide structures 54 may be included in controller 8 for alignment and/or engagement with a charging mechanism

The internal components of controller 8 are best shown in FIGS. 10 and 11, where front cover 50 of controller 8 has been removed. Controller 8 may include a pump 62 in fluid communication with a manifold 64. Manifold 64 is in fluid communication with relief valve 68 and outlet 48. Controller 8 may also include a printed circuit board (PCB) 66 which may include a control circuit and memory. The controller 8 may also include a pressure sensor associated with the pressurized components of the system and the control circuit. The pressure sensor (not shown) may be incorporated into pump 62 and/or placed in pressure sensing communication with manifold 64. Furthermore, the pressure sensor may communicate with the control circuit of PCB 66. The control circuit may be programmed to implement an RIC treatment protocol. The controller may also determine blood pressure during, or as part of, an RIC treatment protocol. To provide convenient mobile usage of system 2, batteries 70 may be arranged, typically in series, to provide a higher operating voltage. Alternatively, batteries 70 may be in electrical communication with a transformer adapted to provide a higher operating voltage. In one embodiment, the operating voltage may be approximately 5 to 6 VDC. In other embodiments, the operating voltage may be approximately 12 VDC or any other appropriate voltage. As shown in FIG. 11, PCB 66 may be connected to the other controller components through plug connector 72.

The control circuit of PCB 66 may be programmed with certain error conditions which may cause the procedure to be aborted or which may cause an indication of the error to appear on a display or which can be used in other known ways. These error conditions may include, but are not limited to: the cuff is not pressurized within a predefined period, such as 20 seconds, 30 seconds, 40 seconds, 50 seconds, or one minute; there is no communication between pump 62 and PCB 66 upon start up; there is no communication between pump 62 and PCB 66 for more than a predefined period, such as two, three. four, or five seconds; multiple consecutive repumps are needed to maintain cuff pressure; pump 62 continues to run and does not respond to an abort signal after a predefined number of retrys, such as three, four, or five retrys; pressure in cuff 4 is not near zero gage pressure within a predefined period, such as 20 seconds, 30 seconds, 40 seconds, 50 seconds, or one minute after the end of an inflation cycle; pressure in cuff 4 is above a predetermined pressure such as 200, 220, 240 or 260 mmHg for longer than a predefined period, such as 5, 10, 20, or 30 seconds; and the pump 62 CPU does not wake up after a command is sent to it by the control circuit. The error condition may be cleared and/or the system may be reset such as by pressing a stop button 76 on the face of controller 8.

During usage, controller 8 may be attached to controller attachment section 6 to place controller outlet 48 into fluid communication with cuff 4. Pressurized gas may then be pumped through controller outlet 48 to inflate the cuff 4. The cuff pressure may be controlled by selectively opening valve 68 in response to a command from the control circuitry of PCB 66. In some embodiments, valve 68 may include a pressure safety relief feature that opens valve 68 in response to an over pressure event during an RIC treatment. In one embodiment, valve 68 opens when the pressure in cuff 4 exceeds 260 mmHg. Valve 68 may open in response to either an error command from the control circuitry of PCB 66, or the valve 68 may include an automatically actuated mechanical system. Controller 8 may also include a slow continuous relief valve. Such a valve would continuously release gas from inflated bladder 20 at a selected rate lower than the rated flow rate of the pump 62. The slow continuous release of gas from bladder 20 could be used to deflate bladder 20 in case of a mechanism failure.

In some embodiments, the control circuit of PCB 66 may be programmable by a health professional and/or an end user according to a prescribed treatment protocol. Alternatively, the control circuit may only be programmed at the factory and may not be altered afterwards by the end user. The control circuitry may also include non-volatile memory for the logging and storage of treatment history. A health care professional may be able to access this memory to determine the treatment history of a patient and determine compliance with a prescribed treatment regime. In another embodiment, the controller may send this information via wireless, or hard wired, communication to a separate receiver for patient records, monitoring, or call center purposes. In one embodiment, controller 8 may include a start button 74 and stop button 76. In some embodiments, the start and stop buttons 74 and 76 may be incorporated into a single button. Controller 8 may also include a hard wired and/or emergency stop button and/or a quick release valve (not shown). In other embodiments, other controls may be included to allow expanded control of an RIC treatment.

In addition to controls, controller 8 may include displays related to the current cycle, the number of cycles left in a treatment, whether the treatment is completed, error signals, charge of the system, and other relevant information. In one embodiment, controller 8 may include a cycle time display 78. Cycle time display 78 may indicate the remaining portion of the inflation/deflation cycle by using illuminated indicators 78a arranged in a circular pattern corresponding to a full inflation/deflation cycle. Each indicator 78a of cycle time display 78 may correspond to a set fraction of the inflation/deflation cycle. When all of the indicators 78a of cycle time display 78 are illuminated, the inflation/deflation cycle is complete. Alternatively, the indicators 78a of cycle time display 78 may start a cycle fully illuminated and sequentially turn off as the cycle proceeds. When each indicator 78a of cycle time display 78 is dark, the particular inflation/deflation cycle is complete. While a circular display has been disclosed, cycle time display 78 could also be arranged in other linear, or non-linear, shapes corresponding to a full cycle. Controller 8 may also include a current cycle display 80, or a digital numeric display, indicating whether the current cycle is the first, second, third, or other cycle. A procedure complete indicator 82 may be illuminated with a solid color or it may blink when the RIC treatment is complete to indicate the end of the procedure. An error display 84 may indicate when an error has occurred by blinking or being fully illuminated. Alternatively, error display 84 may blink in a preset pattern or display a particular color to indicate which error has occurred. A battery charge indicator 86 may indicate the approximate charge remaining in the batteries 70, and may also signal that that the remaining charge is only sufficient for one cycle by blinking.

The above described system may be used for implementing an RIC treatment. The treatment includes placing cuff 4 on a limb of a user and attaching controller 8 to controller attachment section 6 on cuff 4. A user may then press start button 74 to initiate the treatment. Once started the control circuitry of PCB 66 monitors the pressure sensor and turns pump 62 on to inflate the cuff 4. The pressure is then increased to a desired pressure, such as a blood flow occlusion pressure. In one embodiment, the control circuitry of PCB 66 maintains the cuff pressure between preselected pressure limits such as 200 mmHg to 210 mmHg. In other embodiments, the control circuitry of PCB 66 may first determine a systolic blood pressure. After determining a systolic blood pressure, the control circuitry of PCB 66 may subsequently initiate the RIC treatment protocol with a desired pressure such as a pressure greater than the measured systolic blood pressure. Regardless of the specific pressure used, the pressure may be maintained for a selected ischemic duration. Ischemic durations may last on the order of seconds or minutes. After completing the ischemic duration, the controller may activate valve 68 to deflate cuff 4 and initiate the reperfusion duration. Reperfusion durations generally last for at least a minute, although shorter reperfusion durations may be used. After completion of the reperfusion duration another RIC cycle may be conducted. An RIC treatment may include a single cycle or multiple cycles. In one embodiment, an RIC treatment may include four cycles with ischemic durations of approximately 5 minutes, and reperfusion durations of approximately 5 minutes. At the end of the last cycle the cuff 4 may deflate within 30 seconds and the controller 8 may confirm a near zero gage pressure prior to shutting down.

In some embodiments, controller 8 may be charged using a charging cradle 88, as shown in FIG. 12. Charging cradle 88 may include a power connector 90 and mating guide structures 92. In one embodiment, mating guide structures 92 on the charging cradle mate with guide structures 54 on the controller. Mating guide structures 92 act as alignment features. In other embodiments, mating guide structures 92 may be actuated when controller 8 is inserted into the charging cradle 88 to turn the power on and off to power connector 90. Charging cradle 88 may also include a raised area 94 to prevent insertion of the controller while controller 8 is connected to cuff 4 or a patient. In addition to the above, charging cradle 88 may optionally connect with a wall mount portion 96 as shown in FIG. 13.

While the present teachings have been described in conjunction with various embodiments and examples, it is not intended that the present teachings be limited to such embodiments or examples. On the contrary, the present teachings encompass various alternatives, modifications, and equivalents, as will be appreciated by those of skill in the art. Accordingly, the foregoing description and drawings are by way of example only.

Claims

1. A device for remote ischemic conditioning comprising:

an inflatable cuff configured to encircle a limb of a subject;
a controller removably attached to the cuff, wherein the controller comprises: a manifold configured to provide fluid communication between the controller and the cuff; an outlet in fluid communication with the manifold and in removable fluid communication with the inflatable cuff; and a control circuit configured to implement a remote ischemic conditioning treatment protocol; and
a controller attachment section joined to the cuff, the controller attachment section having a bottom surface that substantially conforms to an outer surface of the cuff, wherein the controller is removably attached to the cuff by selective attachment to the controller attachment section disposed on the cuff, the controller attachment section further comprising: an upper surface for supporting the controller in an attached state; an upstanding wall surrounding the upper surface; a tab mounted at one end of the upper surface and including a projecting edge spaced from the upper surface, the projecting edge facing outwardly toward the upstanding wall; and bosses disposed on the upstanding wall on the opposite side of the controller attachment section from the tab;
wherein the controller further comprises a slot that is disposed between a body of the controller and an outer band, and wherein the device is arranged such that when the controller is attached to the controller attachment section, an upper portion of the tab is pushed inwardly away from the upstanding wall so that the tab passes through the slot, and the bosses extend into corresponding recesses provided in the controller body.

2. The device of claim 1, wherein the controller attachment section further includes a conduit that provides sealed, fluid communication between the controller and inflatable cuff.

3. The device of claim 1, wherein cuff pressure is controllable by selectively opening a valve of the controller in response to a command from control circuitry of the control circuit.

4. The device of claim 3, wherein the controller attachment section provides fluid communication between the controller and a bladder of the cuff via a structure that includes a conduit that has a female section constructed and arranged to mate with the controller outlet and a male section that is constructed and arranged to mate with a valve of the bladder of the cuff.

5. The device of claim 1, wherein:

an axial direction of the cuff is substantially parallel to an axis of the limb when the cuff is in a fitted state;
the controller attachment section is operatively attached to the cuff by at least one attachment joint oriented substantially parallel to the axial direction of the cuff; and
the controller attachment section provides fluid communication between the controller and the cuff.

6. The device of claim 1, wherein the controller comprises a slow continuous relief valve that continually releases gas from the cuff at a flow rate lower than a flow rate of the gas being introduced into the cuff.

7. The device of claim 1, wherein the controller further comprises at least one valve configured to open in response to an overpressure event, or in response to an error command from the control circuit.

8. The device of claim 7, wherein the valve opens in response to a command from the controller when a specified condition is detected.

9. The device of claim 1, wherein the control circuit maintains a cuff pressure between pre-selected pressure limits during an ischemic duration of the remote ischemic conditioning treatment protocol.

10. A device for remote ischemic conditioning comprising:

an inflatable cuff configured to encircle a limb of a subject;
a controller removably attached to the cuff, wherein the controller comprises: a manifold configured to provide fluid communication between the controller and the cuff; an outlet in fluid communication with the manifold and in removable fluid communication with the inflatable cuff; and a control circuit configured to implement a remote ischemic conditioning treatment protocol; and
a controller attachment section joined to the cuff, the controller attachment section having a bottom surface that substantially conforms to an outer surface of the cuff, wherein the controller is removably attached to the cuff by selective attachment to the controller attachment section disposed on the cuff;
wherein cuff pressure is controllable by selectively opening a valve of the controller in response to a command from control circuitry of the control circuit;
wherein the controller attachment section provides fluid communication between the controller and a bladder of the cuff via a structure that includes a conduit that has a female section constructed and arranged to mate with the controller outlet and a male section that is constructed and arranged to mate with a valve of the bladder of the cuff; and
wherein the controller outlet has an outer dimension at an end spaced from the controller, and the female section of the conduit has an upper opening that is configured to receive the end of the controller outlet, a cross-sectional size of the upper opening of the female section being greater than the outer dimension of the controller outlet and greater than an inner dimension of the male section.

11. The device of claim 10, further comprising an O-ring seal disposed within the upper opening of the female section, the O-ring seal surrounding and sealing the controller outlet when disposed within the female section.

12. The device of claim 11, wherein a mouth of the upper opening of the female section includes a retaining structure that has an upper surface that forms an acute angle with respect to a direction of elongation of the controller outlet.

13. A device for remote ischemic conditioning comprising:

an inflatable cuff configured to encircle a limb of a subject;
a controller removably attached to the cuff, wherein the controller comprises: an outlet in removable fluid communication with the inflatable cuff; and a control circuit configured to implement a remote ischemic conditioning treatment protocol;
wherein cuff pressure is controllable by selectively opening a valve of the controller in response to a command from control circuitry of the control circuit;
wherein fluid communication between the controller and a bladder of the cuff is provided via a structure that includes a conduit that has a female section constructed and arranged to mate with the controller outlet and a male section that is constructed and arranged to mate with a valve of the bladder of the cuff; and
wherein the controller outlet has an outer dimension at an end spaced from the controller, and the female section of the conduit has an upper opening that is configured to receive the end of the controller outlet, a cross-sectional size of the upper opening of the female section being greater than the outer dimension of the controller outlet.

14. The device of claim 13, wherein the inflatable cuff comprises:

at least two flexible sections spaced apart in a longitudinal direction of the cuff and an intermediate section disposed between the two flexible sections, the intermediate section having a greater rigidity than the two flexible sections; and
a plurality of reinforcing structures disposed on at least one of the two flexible sections and being elongated in an axial direction substantially perpendicular to the longitudinal direction of the cuff, wherein when the cuff is inflated, the reinforcing structures distribute pressure applied by the cuff in the axial direction.

15. The device of claim 14, wherein the plurality of reinforcing structures are spaced apart in a longitudinal direction, and are generally parallel to one another to permit the cuff to bend around an encircled limb while providing increased rigidity in the direction generally perpendicular to the longitudinal direction.

16. The device of claim 14, wherein the reinforcing structures are curved.

17. The device of claim 14, wherein the reinforcing structures are generally linear.

18. The device of claim 14, wherein the reinforcing structures are integrally formed with the flexible sections.

19. The device of claim 18, wherein the reinforcing structures comprise portions of the flexible sections which are uncompressed.

20. The device of claim 14, wherein the reinforcing structures are formed by providing alternating areas of compressed foam and uncompressed foam.

21. The device of claim 14, wherein the reinforcing structures are formed separately from the flexible sections and are attached to at least one of the two flexible sections after formation of the flexible sections.

22. The device of claim 14, wherein the reinforcing structures extend substantially across a width of the cuff.

23. The device of claim 22, wherein the reinforcing structures distribute pressure applied by the cuff across the width of the cuff in the axial direction.

24. The device of claim 14, wherein the reinforcing structures assist in preventing kinks in the cuff assembly.

25. The device of claim 14, further compromising: an outer layer; an inner layer; and an inflatable bladder disposed between the inner layer and the outer layer.

26. The device of claim 25, wherein the reinforcing structures are formed on the outer layer.

27. The device of claim 25, further comprising at least one non-slip structure disposed on an exterior face of the inner layer and configured to face the limb of the subject.

28. The device of claim 27, wherein the non-slip structure comprises a strip formed of silicone.

29. The device of claim 25, wherein the inner layer is formed of a soft, non-irritating material.

30. The device of claim 25, wherein the inner layer is configured to provide moisture absorption, wicking, and/or breathability to the cuff.

31. The device of claim 30, wherein the inner layer comprises a cloth material.

32. The device of claim 31, wherein the cloth material comprises a felt.

33. The device of claim 25, wherein a fluid inlet to the bladder extends from the bladder through the intermediate section of the outer layer.

34. The device of claim 14, further comprising a fastener to couple together ends of the two flexible sections about the limb of the subject.

35. The device of claim 34, wherein the fastener comprises a hook and loop fastener.

36. The device of claim 14, wherein the intermediate section comprises:

a substantially planar upper surface;
an attachment device configured to removably attach the controller to the upper surface; and
the conduit.

37. The device of claim 36, wherein the intermediate section comprises a curved inner surface extending in the longitudinal direction of the cuff.

38. The device of claim 14, further comprising a controller attachment section disposed on the intermediate section, the controller attachment section being configured to permit removable attachment of the controller.

39. The device of claim 38, wherein the controller attachment section is joined to the intermediate section by two attachment joints that are aligned in a direction generally perpendicular to the longitudinal direction of the cuff.

40. A device for remote ischemic conditioning comprising:

an inflatable cuff configured to encircle a limb of a subject;
a controller removably attached to the cuff; and
a controller attachment section joined to the cuff, the controller attachment section having a bottom surface that substantially conforms to an outer surface of the cuff, wherein the controller is removably attached to the cuff by selective attachment to the controller attachment section disposed on the cuff, the controller attachment section further comprising: an upper surface for supporting the controller in an attached state; an upstanding wall surrounding the upper surface; and a tab mounted at one end of the upper surface and including a projecting edge spaced from the upper surface, the projecting edge facing outwardly toward the upstanding wall;
wherein the controller further comprises a slot that is disposed between a body of the controller and an outer band, and wherein the device is arranged such that when the controller is attached to the controller attachment section, an upper portion of the tab is pushed inwardly away from the outstanding wall so that the tab passes through the slot.
Referenced Cited
U.S. Patent Documents
3552383 January 1971 Krueger et al.
4106002 August 8, 1978 Hogue, Jr.
4206764 June 10, 1980 Williams
4294261 October 13, 1981 Baker et al.
4321929 March 30, 1982 Lemelson et al.
4629433 December 16, 1986 Magid et al.
4664651 May 12, 1987 Weinshenker et al.
4690151 September 1, 1987 Utsunomiya et al.
4967758 November 6, 1990 Masciarotte
5072736 December 17, 1991 Ogawa et al.
5135003 August 4, 1992 Souma
5201758 April 13, 1993 Glover
5267565 December 7, 1993 Beard et al.
5569304 October 29, 1996 Ulrich
5571075 November 5, 1996 Bullard et al.
5634467 June 3, 1997 Nevo
5643315 July 1, 1997 Daneshvar
5651369 July 29, 1997 Tomita
5687732 November 18, 1997 Inagaki et al.
5830198 November 3, 1998 Henniges
5970548 October 26, 1999 Welch
6152881 November 28, 2000 Raines et al.
6210423 April 3, 2001 Kim et al.
6245023 June 12, 2001 Clemmons
6251080 June 26, 2001 Henkin et al.
6344025 February 5, 2002 Inagaki et al.
6485429 November 26, 2002 Forstner
6550482 April 22, 2003 Burbank et al.
6626840 September 30, 2003 Drzewiecki et al.
6702720 March 9, 2004 Dardik
6719704 April 13, 2004 Narimatsu et al.
6858012 February 22, 2005 Burns et al.
6905456 June 14, 2005 Brunner et al.
6962599 November 8, 2005 Hui et al.
7004907 February 28, 2006 Banet et al.
7018335 March 28, 2006 Kario et al.
7048702 May 23, 2006 Hui
7111346 September 26, 2006 Inman et al.
7166077 January 23, 2007 Millay et al.
7228576 June 12, 2007 Inman et al.
7314478 January 1, 2008 Hui
7338410 March 4, 2008 Dardik et al.
7374540 May 20, 2008 Schnall et al.
7390303 June 24, 2008 Dafni
7404221 July 29, 2008 Sackner
7427268 September 23, 2008 Millay et al.
7485131 February 3, 2009 Hovanes et al.
7517312 April 14, 2009 Loeb et al.
7689286 March 30, 2010 Pastore et al.
7717855 May 18, 2010 Caldarone et al.
7885710 February 8, 2011 Sih et al.
RE42754 September 27, 2011 Lia
8114026 February 14, 2012 Leschinsky
8123694 February 28, 2012 Kinsley
8246548 August 21, 2012 Naghavi
8672854 March 18, 2014 McCombie
8753283 June 17, 2014 Leschinsky
8764789 July 1, 2014 Ganske et al.
8783499 July 22, 2014 Lacy
8790266 July 29, 2014 Caldarone et al.
8911469 December 16, 2014 Raheman
8986342 March 24, 2015 Naghavi
9119759 September 1, 2015 Caldarone
9119761 September 1, 2015 Caldarone
9205019 December 8, 2015 Ganske
9393025 July 19, 2016 Caldarone
9439574 September 13, 2016 McCombie
9492094 November 15, 2016 Kitamura
9610213 April 4, 2017 Leschinsky
9723985 August 8, 2017 Ono
9743744 August 29, 2017 Maier
20010029389 October 11, 2001 Kim et al.
20030013974 January 16, 2003 Natarajan et al.
20030065270 April 3, 2003 Raines et al.
20030176795 September 18, 2003 Harris et al.
20030216651 November 20, 2003 Burns et al.
20030233118 December 18, 2003 Hui
20040044290 March 4, 2004 Ward et al.
20040064076 April 1, 2004 Bilgi et al.
20040102818 May 27, 2004 Hakky et al.
20040241634 December 2, 2004 Millis et al.
20040255956 December 23, 2004 Vinten-Johansen
20050004476 January 6, 2005 Payvar et al.
20050070405 March 31, 2005 Egger
20050159640 July 21, 2005 Barbut et al.
20050171444 August 4, 2005 Ono et al.
20050177078 August 11, 2005 Loeb et al.
20060052712 March 9, 2006 Poliac et al.
20060052713 March 9, 2006 Poliac et al.
20060052714 March 9, 2006 Poliac et al.
20060058717 March 16, 2006 Hui et al.
20060100639 May 11, 2006 Levin et al.
20060142663 June 29, 2006 Sawanoi et al.
20070005106 January 4, 2007 Adducci
20070055188 March 8, 2007 Avni et al.
20070135836 June 14, 2007 McEwen et al.
20070150005 June 28, 2007 Sih et al.
20070197943 August 23, 2007 Hakonson et al.
20070247304 October 25, 2007 Bonnefin et al.
20080077176 March 27, 2008 Hanlon et al.
20080139949 June 12, 2008 Caldarone et al.
20080222769 September 18, 2008 Natonson et al.
20090036785 February 5, 2009 Danielsson
20090124912 May 14, 2009 McEwen et al.
20090137884 May 28, 2009 Naghavi et al.
20090287069 November 19, 2009 Naghavi et al.
20090318818 December 24, 2009 Whitaker et al.
20090324748 December 31, 2009 Dobson
20100081941 April 1, 2010 Naghavi et al.
20100081977 April 1, 2010 Vess
20100105993 April 29, 2010 Naghavi et al.
20100160799 June 24, 2010 Caldarone et al.
20100185220 July 22, 2010 Naghavi et al.
20100186752 July 29, 2010 Rixson
20100268130 October 21, 2010 Khan
20100292619 November 18, 2010 Redington et al.
20100305607 December 2, 2010 Caldarone et al.
20100322467 December 23, 2010 Reed et al.
20100324429 December 23, 2010 Leschinsky
20100326442 December 30, 2010 Hamilton et al.
20100328142 December 30, 2010 Zoughi et al.
20110077566 March 31, 2011 Ganapathy
20110152650 June 23, 2011 Donehoo et al.
20110190807 August 4, 2011 Redington et al.
20110238107 September 29, 2011 Raheman
20110240043 October 6, 2011 Redington
20110251635 October 13, 2011 Caldarone
20120130419 May 24, 2012 Leschinsky
20120277789 November 1, 2012 Caldarone et al.
20130317581 November 28, 2013 Redington
20140024986 January 23, 2014 Souma
20140296756 October 2, 2014 Ganske et al.
Foreign Patent Documents
201098315 August 2008 CN
201098315 August 2008 CN
200820123637 November 2008 CN
101317805 December 2008 CN
101317805 December 2008 CN
201316381 September 2009 CN
201316381 September 2009 CN
0 960 598 December 1999 EP
0 960 598 December 1999 EP
1 016 379 May 2000 EP
1 249 218 October 2002 EP
1 249 218 October 2002 EP
2 168 553 March 2010 EP
2 301 496 March 2011 EP
1 323 365 July 1973 GB
2001221 January 1990 JP
07-051276 February 1995 JP
2001505472 April 2001 JP
2001505472 April 2001 JP
2002156773 May 2002 JP
2002539879 November 2002 JP
2002539879 November 2002 JP
2 253 429 June 2005 RU
2 253 429 June 2005 RU
WO 83/00995 March 1983 WO
WO 83/00995 March 1983 WO
WO 91/18571 December 1990 WO
WO 91/18571 December 1991 WO
WO 98/30144 July 1998 WO
WO 98/30144 July 1998 WO
WO 00/57776 October 2000 WO
WO 00/57776 October 2000 WO
WO 2005/011503 February 2005 WO
WO 2005/011503 February 2005 WO
WO 2005/051250 June 2005 WO
WO 2005/077265 August 2005 WO
WO 2005/077265 August 2005 WO
WO 2006/024871 March 2006 WO
WO 2006/024871 March 2006 WO
WO 2006/030441 March 2006 WO
WP 2006/030441 March 2006 WO
WO 2006/061825 June 2006 WO
WO 2006/061825 June 2006 WO
WO 2007/085816 August 2007 WO
WO 2007/085828 August 2007 WO
WO 2007/087707 August 2007 WO
WO 2008/148045 December 2008 WO
WO 2008/148062 December 2008 WO
WO 2008/148062 December 2008 WO
WP 2008/148045 December 2008 WO
WO 2009/049103 April 2009 WO
WO 2010/132115 November 2010 WO
WO 2010/132115 November 2010 WO
WO 2011/005538 January 2011 WO
WO 2011/005538 January 2011 WO
WO 2012/024342 February 2012 WO
Other references
  • Addison et al., “Noninvasive remote ischemic preconditioning for global protection of skeletal muscle against infarction,” Am. J. Physiol. Heart Circ. Physiol., vol. 285, pp. 1435-1443 (2003).
  • Ali et al., Remote ischemic preconditioning reduces myocardial and renal injury after elective abdominal aortic aneurysm repair: a randomized controlled trial,: Circulation, vol. 116, 11 Suppl., pp. 98-105 (Sep. 2007).
  • Bartekova et al., “Liver ischemia induced remote preconditioning: role of cardioprotective proteins,” ISHR-ES Meeting, J. Mol. Cell Cardiol., vol. 38, Issue No. 6, p. 1004 (Jun. 21-25, 2005).
  • Botker et al., Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial, Lancet, vol. 375, Issue No. 9716, pp. 727-734 (Feb. 2010).
  • Brzozowski et al., “Ischemic preconditioning of remote organs attenuates gastric ischemia—reperfusion injury through involvement of prostaglandins and sensory nerves,” Eur. J. Pharmacol., vol. 499, Issue Nos. 1-2, pp. 201-213 (Sep. 2004).
  • Cheung et al., “Randomized controlled trial of the effects of remote ischemic preconditioning on children undergoing cardiac surgery: first clinical application in humans,” J. Am. Coll. Cardiol., vol. 47, Issue No. 11, pp. 2277-2282 (Jun. 2006).
  • Dickson et al., “Rabbit heart can be “preconditioned” via transfer of coronary effluent,” Am. J. Physiol., vol. 277, Issue No. 6, Pt. 2, pp. H2451-H2457 (Dec. 1999).
  • Dong et al., “Limb ischemic preconditioning reduces infarct size following myocardial ischemia-reperfusion in rats,” vol. 56, Issue No. 1, pp. 41-46 (Feb. 2004) [Chinese].
  • Dong et al., “Limb ischemic preconditioning reduces infarct size following myocardial ischemia-reperfusion in rats,” vol. 56, Issue No. 1, pp. 41-46 (Feb. 2004) [English abstract].
  • Gho et al., “Myocardial protection by brief ischemia in noncardiac tissue,” Circulation, vol. 94, Issue No. 9, pp. 2193-2200 (Nov. 1996).
  • Hausenloy et al., “Effect of remote ischaemic preconditioning on myocardial injury in patients undergoing coronary artery bypass graft surgery: a randomised controlled trial,” Lancet, vol. 370, Issue No. 9587, pp. 575-579 (Aug. 2007).
  • Hausenloy et al., “Preconditioning and postconditioning: underlying mechanisms and clinical application,” Atherosclerosis, vol. 204, Issue No. 2, pp. 334-341 (Jun. 2009).
  • Hausenloy et al., “The therapeutic potential of ischemic conditioning: an update,” Nat. Rev. Cardiol., vol. 8, Issue No. 11, pp. 619-629 (Jun. 2011).
  • Hoole et al., “Cardiac Remote Ischemic Preconditioning in Coronary Stenting (Crisp Stent) Study: a prospective, randomized control trial” Circulation, vol. 119, Issue No. 6, pp. 820-827 (Feb. 2009).
  • Jenkins et al., “Ischaemic preconditioning reduces troponin T release in patients undergoing coronary artery bypass surgery,” Heart, vol. 77, Issue No. 4, pp. 314-318 (Apr. 1997).
  • Kharbanda et al., “Ischemic preconditioning prevents endothelial injury and systemic neutrophil activation during ischemia-reperfusion in humans in vivo,” Circulation, vol. 103, Issue No. 12, pp. 1624-1630 (Mar. 2001).
  • Kharbanda et al., “Remote ischaemic preconditioning protects against cardiopulmonary bypass-induced tissue injury: a preclinical study,” Heart, vol. 92, Issue No. 10, pp. 1506-1511 (Eur. Pub—Jul. 2006).
  • Kharbanda et al., “Translation of remote ischaemic preconditioning into clinical practice,” Lancet, vol. 374, Issue No. 9700, pp. 1557-1565 (Oct. 2009).
  • Kharbanda et al., “Transient limb ischemia induces remote ischemic preconditioning in vivo,” Circulation, vol. 106, Issue No. 23, pp. 2881-2883 (Dec. 2002).
  • Konstantinov et al., “Remote ischemic preconditioning of the recipient reduces myocardial ischemia-reperfusion injury of the denervated donor heart via a Katp channel-dependent mechanism,” Transplantation, vol. 79, Issue No. 12, pp. 1691-1695 (Jun. 2005).
  • Konstantinov et al., “The remote ischemic preconditioning stimulus modifies inflammatory gene expression in humans,” Physiol Genomics, vol. 19, No. 1, pp. 143-150 (Sep. 2004).
  • Konstantinov et al., “The remote ischemic preconditioning stimulus modifies gene expression in mouse myocardium,” J. Thorac. Cardiovasc. Surg., vol. 130, Issue No. 5, pp. 1326-1332 (Nov. 2005).
  • Lang et al., “Myocardial preconditioning and remote renal preconditioning—identifying a protective factor using proteomic methods?,” Basic Res. Cardiol., vol. 101, Issue No. 2, pp. 149-158 (Mar. 2006).
  • Laskey et al., “Frequency and clinical significance of ischemic preconditioning during percutaneous coronary intervention,” J. Am. Coll. Cardiol., vol. 24, Issue No. 6, pp. 998-1003 (Sep. 2003).
  • Leesar et al., “Nonelectrocardiographic evidence that both ischemic preconditioning and adenosine preconditioning exist in humans,” J. Am. Coll. Cardiol., vol. 42, Issue No. 3, pp. 437-435 (Aug. 2003).
  • Leesar et al., “Preconditioning of human myocardium with adenosine during coronary angioplasty,” Circulation, vol. 95, Issue No. 11, pp. 2500-2507 (Jun. 1997).
  • Loukogeorgakis et al., “Remote ischemic preconditioning provides early and late protection against endothelial ischemia-reperfusion injury in humans: role of the autonomic nervous system,” J. Am. Coll. Cardiol., vol. 46, Issue No. 3, pp. 450-456 (Aug. 2005).
  • Loukogeorgakis et al., “Transient limb ischemia induces remote preconditioning and remote postconditioning in humans by a K(ATP)-channel dependent mechanism,” Circulation, vol. 116, Issue No. 12, pp. 1386-1395 (Sep. 2007).
  • McCully et al., “Adenosine-enhanced ischemic preconditioning: adenosine receptor involvement during ischemia and reperfusion,” Am. J. Physiol. Heart Circ. Physiol., vol. 280, Issue No. 2, pp. H591-H602 (Feb. 2001).
  • Murray et al., “Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium,” Circulation, vol. 74, Issue No. 5, pp. 1 124-1136 (Nov. 1986).
  • Nandagopal et al., “Critical role for nitric oxide signaling in cardiac and neuronal ischemic preconditioning and tolerance,” J. Pharmacol. Exp. Ther., vol. 297, Issue No. 2, pp. 474-478 (May 2001).
  • Peng et al., “The protective effects of ischemic and calcitonin gene-related peptide-induced preconditioning on myocardial injury by endothelin-1 in the isolated perfused rat heart,” Life Sci., vol. 59, Issue No. 18, pp. 1507-1514 (1996).
  • Penttila et al., “Ischemic preconditioning does not improve myocardial preservation during off-pump multivessel coronary operation,” Ann. Thorac. Surg., vol. 75, Issue No. 4, pp. 1246-1252 (Apr. 2003).
  • Peralta et al., “Liver ischemic preconditioning: a new strategy for the prevention of ischemia-reperfusion injury,” Transplant Proc., vol. 35, Issue No. 5, pp. 1800-1802 (Aug. 2003).
  • Przyklenk et al., “Regional ischemic ‘preconditioning’ protects remote virgin myocardium from subsequent sustained coronary occlusion,” Circulation, vol. 87, Issue No. 3, pp. 893-899 (Mar. 1993).
  • Redington et al., “Exploring remote ischaemic preconditioning,” Internal Innovation, pp. 42-44 www.research.media.eu.
  • Saxena et al., “Remote ischemic conditioning: evolution of the concept, mechanisms, and clinical application,” J. Card. Surg., vol. 25, Issue No. 1, pp. 127-134 (Jan.-Feb. 2010).
  • Schmidt et al., “Intermittent peripheral tissue ischemia during coronary ischemia reduces myocardial infarction through a KATP-dependent mechanism: first demonstration of remote ischemic preconditioning,” Am. J. Physiol. Heart Circ. Physiol., vol. 292, Issue No. 4, pp. H1883-H1890 (Apr. 2007).
  • Schoemaker et al., “Bradykinin mediates cardiac preconditioning at a distance,” Am. J. Physiol. Heart Circ. Physiol., vol. 278, Issue No. 5, pp. H1571-1576 (May 2000).
  • Takarada et al., “Applications of vascular occlusion diminish disuse atrophy of knee extensor muscles,” ed. Sci. Sports. Exerc., vol. 32, Issue No. 12, pp. 2035-2039 (Dec. 2000).
  • Tanaka et al., “Expression of heat shock protein after ischemic preconditioning in rabbit hearts,” Jpn. Circ J., vol. 62, Issue No. 7, pp. 512-516 (Jul. 1998).
  • Tejwani et al., “Tourniquet cuff pressure: The gulf between science and practice,” J. Trauma, vol. 61, Issue No. 6, pp. 1415-1418 (Dec. 2006).
  • Tomai et al., “Ischemic preconditioning in humans: models, mediators, and clinical relevance,” Circulation, vol. 100, Issue No. 5, pp. 559-563 (Aug. 1999).
  • Wolfrum et al., “Calcitonin gene related peptide mediates cardioprotection by remote preconditioning,” Regal. Pept., vol. 127, Issue Nos. 1-3 (Apr. 2005).
  • Product ad by Delfi Medical Innovations, Inc., (Delfi tourniquet)(2011).
  • Takarada et al., “Applications of Vascular Occlusion Diminish Disuse Atrophy of Knee Extensor Muscles,” Official Journal of the American College of Sports Medicine, Medicine and Science in Sports and Exercise, pp. 2035-2039 (Apr. 2000).
  • May 29, 2013 Office Action from U.S. Appl. No. 13/542,929.
  • Search Report from PCT Application No. PCT/US2012/033442, no date.
  • Written Opinion from PCT Application No. PCT/US2012/033442, no date.
  • Bøtker et al., Upper-limb ischemia during ambulance transfer reduces myocardial perfusion injury in STEMI. Heartwire. Mar. 28, 2009. Featured at i2 Session of AAC. Mar. 28-31, 2009. Last Accessed on Mar. 5, 2012 from http://www.theheart.org/article/951627.do.
Patent History
Patent number: RE47219
Type: Grant
Filed: Oct 13, 2017
Date of Patent: Feb 5, 2019
Assignee: CellAegis Devices Inc. (Mississauga, Ontario)
Inventors: Rocky Eugene Ganske (Acton), Lahav Gil (Toronto), Adam Shepperdley (Toronto), Raymond Cracauer (Beulah, CO), Igal Royblat (Richmond Hill), Kristopher Thomas Christensen (Oakville), Rade Gadzic (Toronto), Christopher Caldarone (Toronto), Andrew Redington (Cincinnati, OH)
Primary Examiner: Glenn K Dawson
Application Number: 15/783,628
Classifications
Current U.S. Class: Having Means For Varying, Regulating, Indicating, Or Limiting Injection Pressure Or Aspirating Suction (604/118)
International Classification: A61B 17/135 (20060101); A61H 9/00 (20060101); A61B 5/022 (20060101); A61B 17/132 (20060101);